LOX-1 in Ischemic Stroke

Documenti analoghi

• The Discovery of LOX-1, its Ligands and Clinical Significance
  di: Yoshimoto, Ryo, et al.
  Pubblicazione: (2011)
• A Novel Cell-Free, Non-Fluorescent Method to Measure LOX-1-Binding Activity Corresponding to The Functional Activity of HDL
  di: Kakino, Akemi, et al.
  Pubblicazione: (2019)
• Procyanidins are potent inhibitors of LOX-1: a new player in the French Paradox
  di: NISHIZUKA, Taichi, et al.
  Pubblicazione: (2011)
• Deletion of LOX-1 Protects against Heart Failure Induced by Doxorubicin
  di: Yokoyama, Chiharu, et al.
  Pubblicazione: (2016)
• Erratum to “Procyanidins are potent inhibitors of LOX-1: a new player in the French Paradox”: [Proc. Jpn. Acad., Ser. B 87, No. 3, 104–113]
  di: NISHIZUKA, Taichi, et al.
  Pubblicazione: (2011)